This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mapreg. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Barbara Jean Mason: Innovator in Substance Use Disorder Treatment
Introduction
Barbara Jean Mason is a notable inventor based in Rancho Santa Fe, California. She has made significant contributions to the field of substance use disorder treatment through her innovative research and development.
Latest Patents
Mason holds a patent for "Non-bioconvertible C-substituted pregnenolone derivatives for use in the treatment of substance use disorders." This invention focuses on the use of non-bioconvertible C-substituted pregnenolone derivatives, which have no significant affinity for hormonal receptors or receptors of the central nervous system. The patent addresses the treatment of substance use disorders, particularly alcohol use disorder.
Career Highlights
Mason's career is marked by her dedication to advancing medical treatments. She works with Mapreg, a company that focuses on innovative solutions for health-related issues. Her work has the potential to impact many lives by providing new avenues for treatment.
Collaborations
Mason has collaborated with esteemed colleagues such as George F. Koob and Olivier George. These partnerships have enhanced her research and contributed to the development of her patented inventions.
Conclusion
Barbara Jean Mason is a pioneering inventor whose work in the treatment of substance use disorders showcases her commitment to innovation and health. Her contributions are vital in the ongoing fight against addiction and improving patient outcomes.